Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD24 molecule pseudogene 2 is a pseudogene located on human chromosome 15q21.3. Pseudogenes are DNA segments that resemble functional genes but have lost their gene expression or protein-coding ability due to disabling mutations or lack of necessary regulatory elements. While some pseudogenes may have roles in gene regulation (such as acting as decoys for microRNAs or producing regulatory noncoding RNAs), there is no direct evidence that CD24P2 functions as a therapeutic or pharmacological target, nor is it known to be involved in disease mechanisms or to interact with drugs. CD24P2 is annotated with ENSEMBL ID ENSG00000261333 and Entrez Gene ID 936. Its high sequence similarity to the functional CD24 gene may complicate genetic studies due to potential amplification bias in PCR assays. There is no evidence that CD24P2 encodes a functional protein or is involved in signal transduction, cell cycle regulation, or other classic target functions. CD24P2 is not a therapeutic target, does not encode a receptor or enzyme, and is considered a non-functional pseudogene, though its presence may be relevant in genomic analyses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD24 molecule pseudogene 2 (CD24P2).